Huang et al., by using CLDN3 - gene silencing, proved that cell proliferation and tumor growth were reduced and the number of apoptotic cells increased significantly [70], indicating that this protein may be a new target in ovarian cancer treatment, which confirms previous reports [69]. The gene discussed is CLDN3; the disease is ovarian carcinoma.